These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 31281318)

  • 1. Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.
    Lin L; Hu X; Zhang H; Hu H
    Front Immunol; 2019; 10():1398. PubMed ID: 31281318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].
    Fridman WH; Petitprez F; Sautes-Fridman C
    Bull Cancer; 2020 Apr; 107(4):403-404. PubMed ID: 32284150
    [No Abstract]   [Full Text] [Related]  

  • 5. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy.
    Bao X; Lin X; Xie M; Yao J; Song J; Ma X; Zhang X; Zhang Y; Liu Y; Han W; Liang Y; Hu H; Xu L; Xue X
    Front Immunol; 2024; 15():1413067. PubMed ID: 39026670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant Tertiary Lymphoid Organs.
    Ruddle NH
    Transplantation; 2024 May; 108(5):1090-1099. PubMed ID: 37917987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures and their therapeutic implications in cancer.
    Chen X; Wu P; Liu Z; Li T; Wu J; Zeng Z; Guo W; Xiong W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1579-1592. PubMed ID: 39133439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures.
    Li R; Berglund A; Zemp L; Dhillon J; Putney R; Kim Y; Jain RK; Grass GD; Conejo-Garcia J; Mulé JJ
    Front Immunol; 2021; 12():694079. PubMed ID: 34267760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin β receptor and tertiary lymphoid organs shape acute and chronic allograft rejection.
    Zhang G; Feizi N; Zhao D; Halesha L; Williams AL; Randhawa PS; Abou-Daya KI; Oberbarnscheidt MH
    JCI Insight; 2024 Jul; 9(15):. PubMed ID: 38954463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures in cancer: maturation and induction.
    Chen Y; Wu Y; Yan G; Zhang G
    Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients.
    Niu L; Chen T; Yang A; Yan X; Jin F; Zheng A; Song X
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189125. PubMed ID: 38851437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle.
    Lin WP; Li H; Sun ZJ
    EBioMedicine; 2024 Jun; 104():105154. PubMed ID: 38749300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
    Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
    Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
    Domblides C; Rochefort J; Riffard C; Panouillot M; Lescaille G; Teillaud JL; Mateo V; Dieu-Nosjean MC
    Front Immunol; 2021; 12():698604. PubMed ID: 34276690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
    Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
    Front Immunol; 2021; 12():629519. PubMed ID: 33746966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity.
    Silina K; Kroeger D
    Front Immunol; 2019; 10():993. PubMed ID: 31130966
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-Associated Tertiary Lymphoid Structures: A Cancer Biomarker and a Target for Next-generation Immunotherapy.
    Dieu-Nosjean MC
    Adv Exp Med Biol; 2021; 1329():51-68. PubMed ID: 34664233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.